047. COVID-19: Treatment: Thursday, 12:15 - 1:30 p.m.
Poster Session: COVID-19: Treatment
Christopher F. Bell, MS
US Value, Evidence and Outcomes
GlaxoSmithKline
Durham, North Carolina, United States
Tasneem Lokhandwala, PhD
Xcenda LLC
Carrollton, Texas, United States
Daniel C. Gibbons, PhD
GlaxoSmithKline plc., Brentford, Middlesex, UK
Brentford, England, United Kingdom
Myriam Drysdale, PhD
GSK
Brentford, Middlesex, England, United Kingdom
Jane Wang, MS
Xcenda LLC
Carrollton, Texas, United States
Emily Lloyd, MSc
GSK
Brentford, England, United Kingdom